Drug Shortage Report for APO-SERTRALINE

Last updated on 2017-10-04 History
Report ID 14233
Drug Identification Number 02238282
Brand name APO-SERTRALINE
Common or Proper name SERTRALINE
Company Name APOTEX INC
Active Ingredient(s) SERTRALINE
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 250 BTL
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-07-31
Actual start date 2017-07-10
Estimated end date 2017-09-29
Actual end date 2017-09-29
Shortage status Resolved
Updated date 2017-10-04
Company comments APO-SERTRALINE 100 MG CAP 100 BTL
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-10-04 French Compare
v5 2017-10-04 English Compare
v4 2017-07-11 French Compare
v3 2017-07-11 English Compare
v2 2017-06-28 French Compare
v1 2017-06-28 English Compare